Senior judgment for healthcare payer and provider CIOs, PMO leaders, and digital health founders navigating stuck programs — CMS regulatory programs, value-based care analytics, population health platforms, clinical trials systems, and post-merger integration. Bounded 3-month engagements: diagnostic first, peer team co-built, delivery system that stays after I leave.
Diagnostic facilitation and bounded delivery for stuck programs on both sides of the payer-provider relationship.
Each with a named outcome and a fixed price. Easy to start, easy to scope, easy to finish.
Roadmap for AI/ML in population health analytics, RWE pipelines, or clinical trial optimization with a 90-day plan, vendor shortlist, and risk register.
Assessment of clinical trial data systems (EDC/CTMS), RWE databases, or population health infrastructure with prioritized remediations and target architecture.
Async + bi-weekly senior judgment for clinical trials technology decisions, RWE vendor selection, population health platform architecture, and board prep. 6-month minimum.
Fractional CTO owning clinical trial data modernization, population health platform builds, or RWE pipeline delivery. Named accountability for 3–5 outcomes. 3–6 months.
A specialist's edge in data and AI for regulated health environments — without the price tag of a fractional generalist.
Deep expertise in clinical trial data standards (CDISC, CDASH, OMOP, FHIR, QHIN), RWE databases (claims, registries, EHR), and population health analytics for value-based care. Fluent in EDC/CTMS, observational study design, and HIPAA/IRB compliance.
I move between clinical investigators, data scientists, and engineering teams in the same conversation. Decisions get made faster when the room actually understands each other.
Plain-English answers, fast defensible decisions, and a written record of why. Not a contractor handing back code — a partner who owns the outcome with you.
A 30-minute discovery call is structured around five questions: business context, current tech, the decision driving the call, success criteria, and decision timing. No pitch. If it's not the right engagement, I'll say so and offer a referral.
